MedTrace Logo

Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes

NCT03917784 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2019-04-17

No results posted yet for this study

Summary

This study evaluates the effects of oral supplementation with curcumin on the insulin sensitivity in subjects with prediabetes. The half of participants will receive curcumin and bioperine in combination, while the other half receive placebo.

Conditions

Interventions

DRUG

Curcumin

Oral supplementation with curcumin 500 mg oral dosing for 3 months

DRUG

Starch

Oral supplementation with starch 500 mg oral dosing for 3 months

Sponsors & Collaborators

  • Hospital General de México Dr. Eduardo Liceaga

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2019-11-30
Completion
2020-02-28

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03917784 on ClinicalTrials.gov